Management of Mild Depressive Symptoms

Understanding the PHQ-9 Score

• A PHQ-9 score of 7 indicates minimal/mild depressive symptomatology that does not require formal treatment but warrants supportive care, patient education, and scheduled reassessment, according to the American Society of Clinical Oncology guidelines 1, 2
• Patients with a PHQ-9 score of 7 typically demonstrate minimal symptoms of depression with effective coping skills and access to social support 1, 2
• The American Society of Clinical Oncology guidelines consider a PHQ-9 score of 7 to represent none to mild symptomatology 1, 2

Critical Safety Assessment

• The American Society of Clinical Oncology recommends immediately assessing item 9 of the PHQ-9 regarding self-harm thoughts, even if the total score is 7 1, 2
• If the patient endorsed any frequency of thoughts about being better off dead or hurting themselves, immediate referral for emergency psychiatric evaluation is mandatory, regardless of the total score of 7 3, 4

Recommended Management Algorithm

• The American Society of Clinical Oncology guidelines suggest educating the patient about depression, normal stress responses, and the spectrum of depressive symptoms, and normalizing their experience while validating their concerns 5
• The American Society of Clinical Oncology recommends verifying the patient has adequate coping skills and access to social support systems, and identifying any pertinent history or specific risk factors for depression that may warrant closer monitoring 1, 2, 3
• The American Society of Clinical Oncology suggests planning reassessment at future visits rather than initiating treatment, and considering repeat PHQ-9 screening at regular intervals (3, 6, and 12 months) or during times of personal transition, family crisis, or changes in health status 2, 3, 5

Common Pitfalls to Avoid

• The American Society of Clinical Oncology guidelines advise against initiating antidepressant medication or formal psychotherapy for a score of 7, as this represents overtreatment of mild symptoms that typically respond to supportive care and may resolve spontaneously 1, 2, 3
• The American Society of Clinical Oncology recommends never omitting assessment of item 9 regarding self-harm, as a patient can have a low total score but still endorse suicidal ideation, which requires immediate intervention regardless of the overall PHQ-9 result 1, 2, 3, 4

When to Escalate Care

• The American Society of Clinical Oncology guidelines suggest that if repeat PHQ-9 screening shows progression to ≥8, the management approach changes significantly, and scores 8-14 require consultation with psychology or psychiatry for diagnostic confirmation and consideration of low-intensity interventions 3, 4
• The American Society of Clinical Oncology recommends that scores ≥15 mandate immediate referral to psychology and/or psychiatry for formal diagnosis and high-intensity treatment 3, 4, 5

PHQ‑9 Score–Based Referral Guidelines for Oncology Patients

Referral Thresholds by PHQ‑9 Score

• Patients scoring 8–14 (moderate symptoms) should be referred to a psychologist or psychiatrist for diagnostic evaluation, as they typically exhibit the majority of depressive symptoms with mild‑to‑moderate functional impairment【6】【7】.
• Patients scoring ≥15 (moderate‑to‑severe or severe) require immediate referral to psychology and/or psychiatry because they present with the majority of depressive symptoms and moderate‑to‑marked functional interference【6】【7】.
• Patients scoring 1–7 (none/mild) do not need a mental‑health referral; instead, provide education, ensure coping resources, and schedule reassessment at 3, 6, and 12 months or during major life transitions【6】.

Safety Override: Suicidal Ideation (PHQ‑9 Item 9)

• Any endorsement of thoughts about being better off dead or self‑harm on PHQ‑9 item 9 mandates an emergency psychiatric evaluation, irrespective of the total PHQ‑9 score【6】.
• While awaiting evaluation, clinicians should remove access to lethal means and arrange one‑to‑one observation to ensure patient safety【6】.

Rationale for the Lower Cutoff (≥8)

• The ≥8 cutoff is derived from diagnostic‑accuracy studies in cancer outpatients and is supported by a meta‑analysis, demonstrating acceptable sensitivity and specificity across cutoffs 8–11【7】.
• Lowering the threshold from the traditional ≥10 improves sensitivity for detecting major depressive disorder in this population, capturing additional true cases without substantially compromising specificity【7】.

Additional Risk Factors Prompting Immediate Referral (Even with Scores 8–14)

• Presence of any of the following warrants immediate psychiatry referral despite a moderate PHQ‑9 score:

Importance of Including Item 9 in the Assessment

• Omitting item 9 (suicidal ideation) reduces the predictive validity of the PHQ‑9 and may lead to under‑recognition of acute suicide risk, even when total scores are low【7】.

All statements are based on cited evidence from the Journal of Clinical Oncology (2023). The strength of evidence ranges from diagnostic‑accuracy studies to meta‑analytic data supporting the recommended thresholds.

PHQ‑9–Based Management of Depression in Adults

Immediate Safety Assessment

• Assess PHQ‑9 item 9 (thoughts of self‑harm) in every patient before applying any score‑based algorithm. [8][9]10
• Any endorsement of self‑harm thoughts, regardless of total PHQ‑9 score, mandates immediate emergency psychiatric evaluation, one‑to‑one observation, and creation of a safe environment. [8][9]10
• The frequency and specificity of self‑harm thoughts determine the acute risk level and guide the intensity of safety interventions. [9][10]

Mild Symptomatology (PHQ‑9 Score 1‑7)

• No formal pharmacologic or psychotherapeutic treatment is indicated; provide supportive care, patient education (normal stress responses, depressive symptom spectrum, available resources), and schedule reassessment at 3, 6, and 12 months or after major life changes. 8
• Patients in this range typically exhibit minimal depressive symptoms, effective coping skills, and adequate social support. [8][9]

Moderate Symptomatology (PHQ‑9 Score 8‑14)

• Refer to a psychologist or psychiatrist for diagnostic confirmation and determination of the appropriate intervention level. [8][9]10
• The cutoff of ≥ 8 is supported by diagnostic‑accuracy studies and a meta‑analysis showing superior sensitivity compared with the traditional ≥ 10 threshold. 9
• After confirmation, low‑intensity interventions are appropriate, including:
  
  • Structured psychosocial group programs led by licensed mental‑health professionals (stress reduction, coping strategies, social‑support enhancement). 8
  • Individual evidence‑based psychotherapy (cognitive change, behavioral activation, biobehavioral strategies, education, relaxation). 8
  • Pharmacologic treatment with antidepressants selected according to side‑effect profile, drug interactions, prior response, age, and patient preference; monitor adherence and adverse events. 8

Moderate‑to‑Severe (PHQ‑9 Score 15‑19) and Severe (PHQ‑9 Score 20‑27) Symptomatology

• Immediate referral to psychology and/or psychiatry for formal diagnosis and high‑intensity treatment is mandatory. [8][9]10
• Patients in this range experience the majority of depressive symptoms with moderate to marked functional impairment. [8][9]
• High‑intensity interventions include:
  
  • Individual evidence‑based therapy (CBT, behavioral activation, biobehavioral strategies, education, relapse‑prevention components). 8
  • Behavioral couples therapy when a regular partner is present and relationship factors contribute to depression. 8
  • Pharmacologic treatment with close monitoring for efficacy, adherence, and adverse events. 8

Risk Factors Prompting Immediate Referral Even with Moderate Scores (8‑14)

• Presence of any of the following warrants urgent psychiatry referral: prior mood disorder, comorbid mood or anxiety disorder, current or past substance‑use disorder, advanced or progressive medical disease, social isolation (single, widowed, divorced), unemployment with limited finances, low educational attainment (< high‑school), or other chronic illnesses (e.g., coronary heart disease, COPD). 8

Two‑Step Screening Approach

• Step 1: Administer only the first two PHQ‑9 items (anhedonia and depressed mood). [9][10]
• If both items score 0‑1, no further screening is needed. [9][10]
• If either item scores 2‑3 (more than half the days or nearly every day), complete the remaining seven PHQ‑9 items. [9][10]
• This staged process reduces screening burden, with only ≈ 25‑30 % of patients requiring the full questionnaire. 9

Monitoring Treatment Response

• Reassess PHQ‑9 scores at regular intervals during treatment and at 3, 6, and 12 months after treatment completion to track efficacy. [8][9]

Special Populations and Considerations

• Use culturally sensitive assessment tools whenever possible. 10
• Recognize that the PHQ‑9 loses accuracy in patients with cognitive impairment; alternative assessment strategies may be needed. 10
• Detecting depression in older adults can be challenging and may require additional clinical judgment beyond PHQ‑9 scores alone. 10

Common Pitfalls to Avoid

• Failing to assess item 9 (self‑harm) in every patient, regardless of total score. 10
• Using the traditional ≥ 10 cutoff, which reduces sensitivity for detecting clinically significant depression; the ≥ 8 threshold is preferred. 9
• Initiating antidepressants or formal psychotherapy for patients with scores 1‑7, which constitutes overtreatment. [no citation – omitted]
• Managing patients with scores ≥ 15 in primary care without specialist referral; high‑intensity interventions from licensed mental‑health professionals are required. 8